China approves a new, home-grown Alzheimer's drug—and questions immediately follow

4th November 2019 Uncategorised 0

Since Allergan’s Namenda approval in late 2003, the world hasn’t seen a new Alzheimer’s drug for 17 years. That drought was broken Saturday, not by a Western biopharma bigwig with a U.S. approval, but a little-known Chinese firm with a nod in its home country. And suspicions immediately pile on.

More: China approves a new, home-grown Alzheimer's drug—and questions immediately follow
Source: fierce